Medicine
Midodrine 2.5 mg tablet
Midodrine 2.5 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Midodrine
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1 bottle and 48 more
- Manufacturers
- Alembic PharmaceuticalsIndiaZydus LifesciencesIndiaAurobindo PharmaIndiaAvet PharmaceuticalsIndiaLifestar PharmaIndiaBryant Ranch PrepackApotexMajor PharmaceuticalsUpsher-Smith LaboratoriesAdvagen Pharma27 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA17 Midodrine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 September 2003
- Identifiers
- RxCUI 993462, 993466, 993470DailyMed set ID 863f12bd-d4a9-4547-8667-5dfa9e2ce6d1, 0aebf5f9-8cfa-4b77-ba40-821ce0a2b266, db4b18d6-68f9-4d7c-9230-40b928cf859c +32NDC 49884-814, 71205-904, 72162-2560 +32Application ANDA207169, ANDA207849, ANDA212774 +9
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 27 labelers. The register lists 51 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 46708-338-31 | Alembic PharmaceuticalsIndia | 22 January 2021 |
| 500 tablet in 1 bottle | 46708-338-71 | Alembic PharmaceuticalsIndia | 22 January 2021 |
| 100 tablet in 1 bottle | 62332-338-31 | Alembic PharmaceuticalsIndia | 22 January 2021 |
| 500 tablet in 1 bottle | 62332-338-71 | Alembic PharmaceuticalsIndia | 22 January 2021 |
| 100 tablet in 1 bottle | 68382-737-01 | Zydus LifesciencesIndia | 17 September 2020 |
| 100 tablet in 1 bottle | 70771-1595-1 | Zydus LifesciencesIndia | 17 September 2020 |
| 1 bottle in 1 carton / 100 tablet in 1 bottle | 59651-246-01 | Aurobindo PharmaIndia | 10 August 2020 |
| 100 tablet in 1 bottle | 23155-969-01 | Avet PharmaceuticalsIndia | 25 March 2026 |
| 100 tablet in 1 bottle | 70756-010-11 | Lifestar PharmaIndia | 1 November 2023 |
| 100 tablet in 1 bottle | 72888-112-01 | Advagen Pharma | 19 August 2019 |
| 100 tablet in 1 bottle | 60505-1320-1 | Apotex | 12 September 2006 |
| 30 tablet in 1 bottle | 60505-1320-3 | Apotex | 12 September 2006 |
| 500 tablet in 1 bottle | 60505-1320-5 | Apotex | 12 September 2006 |
| 1000 tablet in 1 bottle | 60505-1320-8 | Apotex | 12 September 2006 |
| 90 tablet in 1 bottle | 81469-139-90 | First Nation Group | 13 August 2025 |
| 100 tablet in 1 bottle, plastic | 0378-1901-01 | Mylan Pharmaceuticals | 11 September 2003 |
| 100 tablet in 1 bottle | 82293-003-10 | Novugen Pharma | 18 October 2023 |
| 100 tablet in 1 bottle | 49884-814-01 | Par Health | 29 October 2018 |
| 100 tablet in 1 bottle | 64980-433-01 | Rising Pharma Holdings | 1 April 2019 |
| 100 tablet in 1 bottle | 52817-323-10 | TruPharma | 19 August 2019 |
| 100 tablet in 1 bottle | 85293-005-01 | Umasuto | 5 March 2025 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 0245-0211-01 | Upsher-Smith laboratories | 3 November 2004 |
| 100 tablet in 1 bottle | 0245-0211-11 | Upsher-Smith laboratories | 3 November 2004 |
| 100 tablet in 1 bottle, plastic | 70700-157-01 | Xiromed | 15 October 2020 |
| 100 tablet in 1 bottle | 63629-2227-1 | Bryant Ranch Prepack | 22 March 2021 |
| 100 tablet in 1 bottle, plastic | 63629-2348-1 | Bryant Ranch Prepack | 19 April 2021 |
| 100 tablet in 1 bottle | 71335-3037-1 | Bryant Ranch Prepack | 3 December 2025 |
| 100 tablet in 1 bottle | 72162-1517-1 | Bryant Ranch Prepack | 6 October 2023 |
| 100 tablet in 1 bottle, plastic | 72162-1973-1 | Bryant Ranch Prepack | 7 February 2024 |
| 100 tablet in 1 bottle | 72162-2560-1 | Bryant Ranch Prepack | 4 November 2025 |
| 50 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-6817-06 | Major Pharmaceuticals | 12 September 2006 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-6817-61 | Major Pharmaceuticals | 12 September 2006 |
| 5 blister pack in 1 carton / 10 tablet in 1 blister pack | 0904-7640-06 | Major Pharmaceuticals | 1 September 2026 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 0904-7640-61 | Major Pharmaceuticals | 1 September 2026 |
| 100 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 60687-387-01 | American Health Packaging | 5 June 2019 |
| 90 tablet in 1 bottle | 42291-560-90 | AvKARE | 5 May 2017 |
| 50 tablet in 1 box | 50268-561-15 | AvPAK | 26 August 2019 |
| 90 tablet in 1 bottle, plastic | 51407-388-90 | Golden State Medical Supply | 9 April 2021 |
| 100 tablet in 1 bottle | 72603-605-01 | NorthStar Rx | 21 April 2025 |
| 5 blister pack in 1 carton / 10 tablet in 1 blister pack | 72603-906-05 | NorthStar RxLLC | 15 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 September 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Midodrine
Clinical summary
Midodrine is an alpha-adrenergic agonist indicated for the treatment of symptomatic orthostatic hypotension (OH). It is available as tablets for oral use. MedsAcross supplies Midodrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MidodrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Midodrine Hydrochloride prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Midodrine 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.